Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014
Filters: Author is McCune, Jeannine S [Clear All Filters]
Efficient and stable MGMT-mediated selection of long-term repopulating stem cells in nonhuman primates.. The Journal of clinical investigation. 120(7):2345-54.. 2010.
A pilot pharmacologic biomarker study in HLA-haploidentical hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 72(3):607-18.. 2013.
Aprepitant pharmacokinetics and assessing the impact of aprepitant on cyclophosphamide metabolism in cancer patients undergoing hematopoietic stem cell transplantation.. Journal of clinical pharmacology. 52(4):586-94.. 2012.
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia.. Pediatric blood & cancer.. 2012.
Physiologically based pharmacokinetic modelling of Busulfan: a new approach to describe and predict the pharmacokinetics in adults.. Cancer chemotherapy and pharmacology. 72(5):991-1000.. 2013.
Establishment of long-term tolerance to SRBC in dogs by recombinant canine CTLA4-Ig.. Transplantation. 88(3):317-22.. 2009.
Effects of Garlic on Cytochromes P450 2C9- and 3A4-Mediated Drug Metabolism in Human Hepatocytes.. Scientia pharmaceutica. 78(3):473-481.. 2010.
High prevalence of potential drug interactions affecting mycophenolic acid pharmacokinetics in nonmyeloablative hematopoietic stem cell transplant recipients.. International journal of clinical pharmacology and therapeutics.. 2013.
A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.. Journal of clinical pharmacology. 52(11):1654-64.. 2012.
A pilot pharmacologic biomarker study of busulfan and fludarabine in hematopoietic cell transplant recipients.. Cancer chemotherapy and pharmacology. 69(1):263-272.. 2012.
Personalized dosing of cyclophosphamide in the total body irradiation-cyclophosphamide conditioning regimen: a phase II trial in patients with hematologic malignancy.. Clinical pharmacology and therapeutics. 85(6):615-22.. 2009.
Busulfan in infants to adult hematopoietic cell transplant recipients: A population pharmacokinetic model for initial and Bayesian dose personalization.. Clinical cancer research : an official journal of the American Association for Cancer Research.. 2013.
Busulfan in hematopoietic stem cell transplant setting.. Expert opinion on drug metabolism & toxicology. 5(8):957-69.. 2009.
Variation in prescribing patterns and therapeutic drug monitoring of intravenous busulfan in pediatric hematopoietic cell transplant recipients.. Journal of clinical pharmacology. 53(3):264-75.. 2013.
Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.. 2013.
Potential contribution of cytochrome P450 2B6 to hepatic 4-hydroxycyclophosphamide formation: in vitro and in vivo investigations.. Drug metabolism and disposition: the biological fate of chemicals. 40(1):54-63.. 2012.
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer.. The American journal of managed care. 16(9):678-86.. 2010.
Patterns of blood product use among patients with myelodysplastic syndrome.. Vox sanguinis. 102(4):331-337.. 2012.
Cyclophosphamide followed by intravenous targeted busulfan for allogeneic hematopoietic cell transplantation: pharmacokinetics and clinical outcomes.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(7):1033-9.. 2013.
Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300.. 2010.
A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7.. 2009.
Health care use and primary prophylaxis with colony-stimulating factors.. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 14(2):247-52.. 2011.
Pharmacogenomic associations in ABCB1 and CYP3A5 with acute kidney injury and chronic kidney disease after myeloablative hematopoietic cell transplantation.. The pharmacogenomics journal. 8(4):248-55.. 2008.
Doing Business with Arnold Library
Weintraub Building, B1-010
More About Arnold Library
- Information for Grant Writers
- Arnold Library News
- Affiliations and Memberships
- Journals List
- Web of Science - Science Citation Index
- Pubmed (Get Article Enabled)
- Library Catalog
- Document Delivery Form
- Center-Authored Papers
- Institutional Repository
- Researcher Profiles